Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
Malcolm A. Smith(National Cancer Institute), Richard S. Ungerleider(Unknown), Paul S. Gaynon(University of Southern California), Jonathan J. Shuster(Health Outcomes Solutions (United States)), Jeanette Pullen, RD Gelber, Andrew J. Carroll(University of Alabama at Birmingham), Stephen E. Sallan, Edward L. Korn(National Cancer Institute), Fatih M. Uckun(University of Southern California), D Arthur(Fairview Health Services), WM Crist(Unknown), Nyla A. Heerema(The Ohio State University), Réka Simon, Michael P. Link(Stanford University), M Trigg, Harland N. Sather(Children's Oncology Group), Bruce M. Camitta(Medical College of Wisconsin), D G Tubergen, Ching‐Hon Pui(St. Jude Children's Research Hospital), S B Murphy(Children's Oncology Group), G Reamon
Cited by 914
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934